Standout Papers

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patien... 2007 2026 2013 2019 523
  1. Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 (2007)
    Robert G. Maki, J. Kyle Wathen et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 12 from Science/Nature 56 standout
Sub-graph 1 of 19

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Carbon-to-nitrogen single-atom transmutation of azaarenes
2023 StandoutNature
5 intermediate papers

Works of David C. Harmon being referenced

Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer
2012
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
2011
and 2 more

Author Peers

Author Last Decade Papers Cites
David C. Harmon 4504 3107 1587 128 7.0k
A. Zoubek 4545 1597 1558 100 6.4k
Emmanuelle Bompas 3990 2560 1139 193 5.6k
Sant P. Chawla 5185 3829 2253 291 9.4k
Gaetano Bacci 6195 2372 3007 123 8.5k
Alessandra Longhi 5250 1943 2800 171 7.2k
Teresa J. Vietti 4473 2192 1598 149 7.9k
Ole S. Nielsen 3441 2128 661 117 5.9k
Gerald Rosen 6001 2582 2704 151 8.1k
Scott H. Okuno 3486 2482 717 177 5.7k
Jonathan C. Trent 4936 2384 959 276 7.9k

All Works

Loading papers...

Rankless by CCL
2026